<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Pediatr</journal-id><journal-id journal-id-type="iso-abbrev">Front Pediatr</journal-id><journal-id journal-id-type="publisher-id">Front. Pediatr.</journal-id><journal-title-group><journal-title>Frontiers in Pediatrics</journal-title></journal-title-group><issn pub-type="epub">2296-2360</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6536658</article-id><article-id pub-id-type="doi">10.3389/fped.2019.00202</article-id><article-categories><subj-group subj-group-type="heading"><subject>Pediatrics</subject><subj-group><subject>Original Research</subject></subj-group></subj-group></article-categories><title-group><article-title>A Presumed Etiology of Kawasaki Disease Based on Epidemiological Comparison With Infectious or Immune-Mediated Diseases</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Rhim</surname><given-names>Jung-Woo</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/599301/overview"/></contrib><contrib contrib-type="author"><name><surname>Kang</surname><given-names>Hyun Mi</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Han</surname><given-names>Ji-Whan</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/724665/overview"/></contrib><contrib contrib-type="author"><name><surname>Lee</surname><given-names>Kyung-Yil</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="corresp" rid="c001"><sup>*</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/528400/overview"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Department of Pediatrics, College of Medicine, The Catholic University of Korea</institution>, <addr-line>Seoul</addr-line>, <country>South Korea</country></aff><aff id="aff2"><sup>2</sup><institution>Department of Pediatrics, Daejeon St. Mary's Hospital, The Catholic University of Korea</institution>, <addr-line>Daejeon</addr-line>, <country>South Korea</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Claudio Pignata, University of Naples Federico II, Italy</p></fn><fn fn-type="edited-by"><p>Reviewed by: Elma In&#x000e9;s Nievas, Independent Researcher, Mendoza, Argentina; Piero Pavone, Universit&#x000e0; degli Studi di Catania, Italy</p></fn><corresp id="c001">*Correspondence: Kyung-Yil Lee <email>leekyungyil@catholic.ac.kr</email></corresp><fn fn-type="other" id="fn001"><p>This article was submitted to Pediatric Immunology, a section of the journal Frontiers in Pediatrics</p></fn></author-notes><pub-date pub-type="epub"><day>21</day><month>5</month><year>2019</year></pub-date><pub-date pub-type="collection"><year>2019</year></pub-date><volume>7</volume><elocation-id>202</elocation-id><history><date date-type="received"><day>30</day><month>10</month><year>2018</year></date><date date-type="accepted"><day>30</day><month>4</month><year>2019</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2019 Rhim, Kang, Han and Lee.</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Rhim, Kang, Han and Lee</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p><bold>Background:</bold> Kawasaki disease (KD) may be associated with infection of unknown pathogen(s). For predicting of the etiology of KD, we evaluated epidemiological characteristics in KD, common infectious diseases and immune-mediated diseases in childhood.</p><p><bold>Methods:</bold> We respectively, reviewed the data of patients with KD, influenza, aseptic meningitis, exanthem subitum (ES), <italic>Mycoplasma pneumoniae</italic> (MP) pneumonia, acute pyelonephritis (APN), Henoch-Sch&#x000f6;nlein purpura (HSP), acute poststreptococcal glomerulonephritis (APSGN), and childhood asthma. We compared and interpreted epidemiological data across the groups.</p><p><bold>Results:</bold> In age distribution, KD, APN, and ES showed a similar pattern in that majority of patients were infants or young children, and other diseases showed a relatively even age-distribution which had a peak age, mainly 5&#x02013;6 years, with bell-shape patterns. In annual-case pattern, there were epidemic years in aseptic meningitis and MP pneumonia, and the fluctuated annual cases were seen in other diseases. The trends of decreasing cases were seen in APSGN, HSP, and childhood asthma in recent years. In seasonal frequency, influenza or aseptic meningitis occurred in mainly winter or summer season, respectively. HSP and APSGN cases had less in summer, and KD, APN, and ES showed relatively even occurrence throughout a year without significant seasonal variations.</p><p><bold>Conclusions:</bold> Our results suggest that KD agents may be associated with normal flora that are influenced by environmental changes, since pathogens of APN and ES could be regarded as normal flora that originate from the host itself or ubiquitously existing human reservoirs.</p></abstract><kwd-group><kwd>Kawasaki disease</kwd><kwd>etiology</kwd><kwd>epidemiology</kwd><kwd>acute pyelonephritis</kwd><kwd>exanthem subitum</kwd><kwd>microbiota</kwd></kwd-group><counts><fig-count count="3"/><table-count count="2"/><equation-count count="0"/><ref-count count="61"/><page-count count="9"/><word-count count="6461"/></counts></article-meta></front><body><sec sec-type="intro" id="s1"><title>Introduction</title><p>Kawasaki disease (KD) disease was a novel disease that appeared in East Asian countries in the order of Japan, South Korea, Taiwan, and China with a 5&#x02013;10 year time-gap (<xref rid="B1" ref-type="bibr">1</xref>&#x02013;<xref rid="B4" ref-type="bibr">4</xref>). After the first case report in the 1960s in Japan, KD has been reported in over 60 countries around the world (<xref rid="B5" ref-type="bibr">5</xref>). However, the incidence of KD is different across various populations; currently, the incidence in Western countries is lower by one tenth to one twentieth compared to East Asian countries, and has plateaued during recent decades. Whereas, the number of KD patients in East Asian countries has slowly and steadily increased after its first emergence (<xref rid="B6" ref-type="bibr">6</xref>). In these countries, KD occurs mostly in children between 6 months and 4 years of age, and has become a nationwide endemic disease within 2 decades after its first appearance. These findings suggest that KD spreads slowly to other regions within a nation and neighboring countries, which is contrasting to common infectious disease epidemics. KD pathogen(s) should satisfy with the epidemiological characteristics of KD.</p><p>The clinical manifestations of Kawasaki disease share similarities in some aspects of viral diseases, bacterial diseases, or infection-related immune mediated diseases such as systemic juvenile idiopathic rheumatoid arthritis or acute rheumatic fever (ARF). However, extensive studies searching for the etiologic agent(s) have turned up as failures until the present time (<xref rid="B7" ref-type="bibr">7</xref>). Common childhood infectious diseases and infection-related immune-mediated diseases, including KD, childhood idiopathic thrombocytopenia, and Henoch-Sch&#x000f6;nlein purpura (HSP) have low prevalence in older children and adults. Thus, these childhood diseases have been hypothesized to be associated with infections caused by unknown pathogens (<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B9" ref-type="bibr">9</xref>). Since KD is an acute self-limiting systemic inflammation that involves multiple organs, it has been proposed that there are etiologic substances that induce systemic inflammation and target cell injuries, including coronary artery lesions (CALs), during or after the infection with KD pathogen (s) (<xref rid="B10" ref-type="bibr">10</xref>). Also, it has been proposed that KD pathogens may be a species of the host's normal flora based on clinical and epidemiological characteristics of KD (<xref rid="B11" ref-type="bibr">11</xref>). The epidemiological characteristics of a disease may aid in predicting the etiologic agent(s) of the disease. The identification of KD etiology is essential for understanding the disease, and the development of diagnostic tools and adequate treatment modalities.</p><p>In this study, to predict the etiology of KD, we evaluated and compared epidemiological characteristics between KD and common infectious diseases or immune-mediated diseases in children. After evaluating epidemiological parameters focused on age distribution, annual-case pattern and monthly-case pattern, we found that the epidemiological profiles in KD were similar to those in acute pyelonephritis (APN) or exanthema subitum (ES). We discussed the implications of these findings in KD epidemiology in Korea.</p></sec><sec sec-type="materials and methods" id="s2"><title>Materials and Methods</title><p>The subjects of this study were collected from the patients (0&#x02013;15 years of age) who were admitted at The Catholic University of Korea Daejeon St. Mary's Hospital from January 1987 to December 2016. We evaluated the epidemiological characteristics of patients diagnosed with <italic>Mycoplasma pneumoniae</italic> (MP) pneumonia, influenza, aseptic meningitis, APN, ES, acute poststreptococcal glomerulonephritis (APSGN), HSP, childhood asthma (or recurrent wheezing episode), and KD. As an exception, the subjects diagnosed with influenza in this study were selected from outpatients who were positive for influenza in rapid diagnostic testing during the winter of influenza seasons. The diagnosis or selection criteria in each disease were referenced from other publications (<xref rid="B12" ref-type="bibr">12</xref>&#x02013;<xref rid="B20" ref-type="bibr">20</xref>). Although the study period and the number of patients in each disease were not identical, we reevaluated the data that were used for previously published papers or collected new data for some diseases such as ES and HSP. Age, sex, age distribution pattern, annual-case pattern and monthly-case pattern were analyzed in each disease. For mean age, &#x0003c;12 months of age was regarded as 0 years of age for statistical analyses, except ES. In age distribution pattern, we focused on age predilection in infancy and younger children. In annual-case pattern, we searched whether the pattern shown cyclic epidemics during the study periods. As for seasonal variation, the disease was regarded as having seasonality when the number of seasonal cases showed over 10 or 15% difference in the number of cases between the highest season and the lowest season.</p><sec><title>Ethics Statement</title><p>The written informed consents were obtained from the parents/caregivers of all children for the medical records to be used in this study at time of admission. The study was approved by the Institutional Review Board of The Catholic University of Korea Daejeon St. Mary's Hospital (DC18RESI0100).</p></sec></sec><sec sec-type="results" id="s3"><title>Results</title><p>A total of 7,832 patients diagnosed with 9 diseases, including KD, 5 infectious diseases, and 3 immune-mediated diseases were evaluated. The study period in the majority of diseases was over 10 years; for infectious diseases, MP pneumonia (2003&#x02013;2012, <italic>n</italic> = 779) (<xref rid="B12" ref-type="bibr">12</xref>), influenza (2010&#x02013;2017, <italic>n</italic> = 2,163) [(<xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B14" ref-type="bibr">14</xref>), unpublished observation], aseptic meningitis (1987&#x02013;2003, <italic>n</italic> = 2,201) (<xref rid="B15" ref-type="bibr">15</xref>), APN (2005&#x02013;2015, <italic>n</italic> = 320) (<xref rid="B16" ref-type="bibr">16</xref>) and ES (2005&#x02013;2016, <italic>n</italic> = 429), and as for infection-related immune diseases, APSGN (1987&#x02013;2013, <italic>n</italic> = 99) (<xref rid="B17" ref-type="bibr">17</xref>), HSP (1987&#x02013;2015, <italic>n</italic> = 515) (unpublished observation) and childhood asthma (or recurrent wheezing episode) (2003&#x02013;2014, <italic>n</italic> = 384) (<xref rid="B18" ref-type="bibr">18</xref>), and KD (1987&#x02013;2016, <italic>n</italic> = 942) (<xref rid="B19" ref-type="bibr">19</xref>, <xref rid="B20" ref-type="bibr">20</xref>) (<xref rid="T1" ref-type="table">Table 1</xref>).</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Demographic findings in KD and other diseases (0&#x02013;15 years of age).</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"><bold>Diseases</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>Study period</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>No. of subjects</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>Mean cases/y</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>M:F ratio</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>Mean age (y)</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>Peak ages (y)</bold></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Kawasaki disease</td><td valign="top" align="center" rowspan="1" colspan="1">1987&#x02013;2016</td><td valign="top" align="center" rowspan="1" colspan="1">942</td><td valign="top" align="center" rowspan="1" colspan="1">31</td><td valign="top" align="center" rowspan="1" colspan="1">1.7:1</td><td valign="top" align="center" rowspan="1" colspan="1">2.2 &#x000b1; 1.6</td><td valign="top" align="center" rowspan="1" colspan="1">1</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Mycoplasma pneumonia</td><td valign="top" align="center" rowspan="1" colspan="1">2003&#x02013;2012</td><td valign="top" align="center" rowspan="1" colspan="1">779</td><td valign="top" align="center" rowspan="1" colspan="1">78</td><td valign="top" align="center" rowspan="1" colspan="1">1.1:1</td><td valign="top" align="center" rowspan="1" colspan="1">5.0 &#x000b1; 3.2</td><td valign="top" align="center" rowspan="1" colspan="1">4</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Influenza</td><td valign="top" align="center" rowspan="1" colspan="1">2010&#x02013;2018</td><td valign="top" align="center" rowspan="1" colspan="1">2,163<xref ref-type="table-fn" rid="TN1"><sup>*</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">270</td><td valign="top" align="center" rowspan="1" colspan="1">1.1:1</td><td valign="top" align="center" rowspan="1" colspan="1">5.4 &#x000b1; 3.8</td><td valign="top" align="center" rowspan="1" colspan="1">3&#x02013;5</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Aseptic meningitis</td><td valign="top" align="center" rowspan="1" colspan="1">1987&#x02013;1998</td><td valign="top" align="center" rowspan="1" colspan="1">2,201</td><td valign="top" align="center" rowspan="1" colspan="1">115</td><td valign="top" align="center" rowspan="1" colspan="1">2:1</td><td valign="top" align="center" rowspan="1" colspan="1">6.0 &#x000b1; 3.9</td><td valign="top" align="center" rowspan="1" colspan="1">4&#x02013;6</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Acute pyelonephritis</td><td valign="top" align="center" rowspan="1" colspan="1">2005&#x02013;2015</td><td valign="top" align="center" rowspan="1" colspan="1">320</td><td valign="top" align="center" rowspan="1" colspan="1">29</td><td valign="top" align="center" rowspan="1" colspan="1">1.4:1</td><td valign="top" align="center" rowspan="1" colspan="1">1.5 &#x000b1; 3.4</td><td valign="top" align="center" rowspan="1" colspan="1">0</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Exanthem subitum</td><td valign="top" align="center" rowspan="1" colspan="1">2005&#x02013;2016</td><td valign="top" align="center" rowspan="1" colspan="1">429</td><td valign="top" align="center" rowspan="1" colspan="1">36</td><td valign="top" align="center" rowspan="1" colspan="1">1:1</td><td valign="top" align="center" rowspan="1" colspan="1">1.0 &#x000b1; 0.5</td><td valign="top" align="center" rowspan="1" colspan="1">0</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">APSGN</td><td valign="top" align="center" rowspan="1" colspan="1">1987&#x02013;2014</td><td valign="top" align="center" rowspan="1" colspan="1">99</td><td valign="top" align="center" rowspan="1" colspan="1">4</td><td valign="top" align="center" rowspan="1" colspan="1">2.3:1</td><td valign="top" align="center" rowspan="1" colspan="1">8.3 &#x000b1; 2.7</td><td valign="top" align="center" rowspan="1" colspan="1">7&#x02013;9</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Henoch-Sh&#x000f6;nlein purpura</td><td valign="top" align="center" rowspan="1" colspan="1">1987&#x02013;2015</td><td valign="top" align="center" rowspan="1" colspan="1">515</td><td valign="top" align="center" rowspan="1" colspan="1">18</td><td valign="top" align="center" rowspan="1" colspan="1">1.2:1</td><td valign="top" align="center" rowspan="1" colspan="1">6.5 &#x000b1; 3.0</td><td valign="top" align="center" rowspan="1" colspan="1">5</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Childhood asthma</td><td valign="top" align="center" rowspan="1" colspan="1">2003&#x02013;2014</td><td valign="top" align="center" rowspan="1" colspan="1">384</td><td valign="top" align="center" rowspan="1" colspan="1">32</td><td valign="top" align="center" rowspan="1" colspan="1">1.2:1</td><td valign="top" align="center" rowspan="1" colspan="1">5.6 &#x000b1; 3.5</td><td valign="top" align="center" rowspan="1" colspan="1">2&#x02013;4</td></tr></tbody></table><table-wrap-foot><fn id="TN1"><label>*</label><p><italic>Outpatients; APSGN, acute poststreptoccocal glomerulonephritis</italic>.</p></fn></table-wrap-foot></table-wrap><sec><title>Age, Sex, and Age Distribution in KD and Other Diseases</title><p>The male-to-female (M:F) ratio, mean age, and peak ages are shown in <xref rid="T1" ref-type="table">Table 1</xref>.</p><p>Male predominance was observed in all the diseases except ES (0.95:1), but the M:F ratios were somewhat different across the diseases. The highest M:F ratio was seen in APSGN (2.3:1), and the lower M:F ratios were seen in ES, MP pneumonia and influenza (1.1:1, respectively), and KD showed 1.7:1 ratio in this series. The lowest mean age was noted in order of ES (mean 1 year of age), APN (1.5 years), and KD (2.2 years) and the higher mean age was noted in APSGN (8.3 years) and HSP (6.5 years). In age distribution, KD, APN, and ES showed a similar pattern in that the majority of patients were infants and young children (0&#x02013;4 years), and after this age period the prevalence decreased dramatically. There were only a few patients &#x0003e;3 years of age in ES and a few patients &#x0003e;5 years in KD, however there was relatively an even distribution with female predominance after &#x0003e;2 years in APN. A bell-shape distribution pattern with a peak prevalence, mainly in the 4&#x02013;6 years age range was observed in other diseases, however peak ages were slightly different across the diseases (<xref ref-type="fig" rid="F1">Figure 1</xref>). There was a trend where the peak ages were changed in the epidemic diseases such as MP pneumonia and influenza over time [(<xref rid="B12" ref-type="bibr">12</xref>), unpublished observation].</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>Age distribution in Kawasaki disease and other infectious or infection-related immune-mediated diseases.</p></caption><graphic xlink:href="fped-07-00202-g0001"/></fig></sec><sec><title>Annual-Case Patterns in KD and Other Diseases</title><p>Cyclic epidemics caused by possibly new strains of pathogens, such as macrolide-resistant strains were noted in MP pneumonia and in aseptic meningitis caused by mainly enteroviruses; all had similar patterns with nationwide epidemics or outbreaks in Korea (<xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B15" ref-type="bibr">15</xref>). Influenza occurred every winter and early spring, but the number of cases and peak epidemic months were different in 2009 pandemic and seasonal influenza, across seasonal influenza after 2009 pandemic [(<xref rid="B14" ref-type="bibr">14</xref>), unpublished observation]. Relatively an even, but fluctuating annual cases were noted in KD, APN, ES, HSP, and childhood asthma, except APSGN (<xref ref-type="fig" rid="F2">Figure 2</xref>). The mean annual cases in each disease are shown <xref rid="T1" ref-type="table">Table 1</xref>, and the results may be helpful to estimate the incidence of each disease in our city, since nationwide KD epidemiological studies in Korea have been performed every 3 years (<xref rid="B21" ref-type="bibr">21</xref>, <xref rid="B22" ref-type="bibr">22</xref>). There was a trend of decreasing number of cases in the recent years or decades in APSGN, HSP and childhood asthma, whereas an increasing trend was noted in APN, compared to the past years or decades (<xref ref-type="fig" rid="F2">Figure 2</xref>).</p><fig id="F2" position="float"><label>Figure 2</label><caption><p>Annual cases in KD and other diseases.</p></caption><graphic xlink:href="fped-07-00202-g0002"/></fig></sec><sec><title>Monthly or Seasonal-Case Pattern in KD and Other Diseases</title><p>A higher number of cases were seen in the fall and winter in MP pneumonia. Aseptic meningitis was noted mainly during the summer whereas influenza mainly during winter and early spring seasons. There was a trend showing a lower number of cases in the summer in HSP, and a higher number of cases in the winter for APSGN. A higher number of cases were seen during the fall and spring for childhood asthma. Although KD affected more patients during summer than any other season in this series, KD had no difference in seasonal variation according to the definition of the seasonality. Also, no seasonality was seen in APN and ES (<xref rid="T2" ref-type="table">Table 2</xref> and <xref ref-type="fig" rid="F3">Figure 3</xref>).</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Seasonality in KD and other diseases.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"><bold>Diseases</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>Spring (%)</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>Summer (%)</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>Fall (%)</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>Winter (%)</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Seasonality</bold></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Kawasaki disease</td><td valign="top" align="center" rowspan="1" colspan="1">22.9</td><td valign="top" align="center" rowspan="1" colspan="1">27.7</td><td valign="top" align="center" rowspan="1" colspan="1">23.1</td><td valign="top" align="center" rowspan="1" colspan="1">26.2</td><td valign="top" align="left" rowspan="1" colspan="1">No seasonality</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Mycoplasma pneumonia</td><td valign="top" align="center" rowspan="1" colspan="1">11.2</td><td valign="top" align="center" rowspan="1" colspan="1">19.1</td><td valign="top" align="center" rowspan="1" colspan="1">48.4</td><td valign="top" align="center" rowspan="1" colspan="1">21.3</td><td valign="top" align="left" rowspan="1" colspan="1">Fall predominance</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Influenza</td><td valign="top" align="center" rowspan="1" colspan="1">45.3</td><td valign="top" align="center" rowspan="1" colspan="1">0.2</td><td valign="top" align="center" rowspan="1" colspan="1">0.1</td><td valign="top" align="center" rowspan="1" colspan="1">54.4</td><td valign="top" align="left" rowspan="1" colspan="1">Spring, winter</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Aseptic meningitis</td><td valign="top" align="center" rowspan="1" colspan="1">22.2</td><td valign="top" align="center" rowspan="1" colspan="1">63.5</td><td valign="top" align="center" rowspan="1" colspan="1">12.3</td><td valign="top" align="center" rowspan="1" colspan="1">1.9</td><td valign="top" align="left" rowspan="1" colspan="1">Summer predominance</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Acute pyelonephritis</td><td valign="top" align="center" rowspan="1" colspan="1">26.9</td><td valign="top" align="center" rowspan="1" colspan="1">27.8</td><td valign="top" align="center" rowspan="1" colspan="1">23.1</td><td valign="top" align="center" rowspan="1" colspan="1">22.2</td><td valign="top" align="left" rowspan="1" colspan="1">No seasonality</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Exanthem subitum</td><td valign="top" align="center" rowspan="1" colspan="1">28.4</td><td valign="top" align="center" rowspan="1" colspan="1">31.7</td><td valign="top" align="center" rowspan="1" colspan="1">18.6</td><td valign="top" align="center" rowspan="1" colspan="1">21.8</td><td valign="top" align="left" rowspan="1" colspan="1">No seasonality</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">APSGN</td><td valign="top" align="center" rowspan="1" colspan="1">21.2</td><td valign="top" align="center" rowspan="1" colspan="1">12.1</td><td valign="top" align="center" rowspan="1" colspan="1">30.3</td><td valign="top" align="center" rowspan="1" colspan="1">36.4</td><td valign="top" align="left" rowspan="1" colspan="1">Winter, fall</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Henoch-Sh&#x000f6;nlein purpura</td><td valign="top" align="center" rowspan="1" colspan="1">31.1</td><td valign="top" align="center" rowspan="1" colspan="1">13.6</td><td valign="top" align="center" rowspan="1" colspan="1">29.1</td><td valign="top" align="center" rowspan="1" colspan="1">26.2</td><td valign="top" align="left" rowspan="1" colspan="1">Low in summer</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Childhood asthma</td><td valign="top" align="center" rowspan="1" colspan="1">26.8</td><td valign="top" align="center" rowspan="1" colspan="1">13.5</td><td valign="top" align="center" rowspan="1" colspan="1">43</td><td valign="top" align="center" rowspan="1" colspan="1">16.7</td><td valign="top" align="left" rowspan="1" colspan="1">Fall, Spring</td></tr></tbody></table><table-wrap-foot><p><italic>APSGN, acute poststreptococcal glomerulonephritis</italic>.</p></table-wrap-foot></table-wrap><fig id="F3" position="float"><label>Figure 3</label><caption><p>Monthly or seasonal distribution of cases in KD and other diseases.</p></caption><graphic xlink:href="fped-07-00202-g0003"/></fig></sec></sec><sec sec-type="discussion" id="s4"><title>Discussion</title><p>It is hypothesized that KD may have an etiologic agent(s), although many studies searching for the etiology of KD have failed. Etiologic agents in infectious diseases originate from an external source and invade into the host. However, at present time, they could be classified as exogenous pathogens and the endogenous pathogens; the former is generally accepted as agents that are newly introduced to humans from other animal species or other places, whereas the latter originates from the host in the forms of normal flora (or commensals) or those becoming a normal flora from initially being an exogenous pathogen. For examples, measles in immune-innocent populations in the past and acquired immunodeficiency syndrome (AIDS) were caused by new external pathogens. On the other hand, the pathogens causing APN or acute otitis media, such as <italic>E. coli</italic> or <italic>Streptococcus pneumoniae</italic>, could be categorized as endogenous pathogens. It is well-known that a newly introduced disease by an exogenous pathogen has affected all aged persons in a population and spread to other populations in relatively a short-time period of time after its first emergence. Over time, infected persons and groups have immunity to the pathogens, and young children and infants would remain susceptible, especially during cyclic epidemic viral infections. Accordingly, epidemiologic characteristics of infectious diseases or infection-related diseases in the populations at a given time may differ.</p><p>In the present study, we found that epidemiological characteristics in KD were most similar to those in APN or ES among the 8 evaluated diseases. In age distribution, these 3 diseases had an age predilection in infancy and young children; 79.7% of patients in APN, 95.8% in ES, and 50.1% in KD were 0&#x02013;1 years of age, and 87.5% of patients in APN, near 100% in ES, and 91.7% in KD were 0&#x02013;4 years of age. In the view of epidemiological and clinical aspects, an infected infant with pathogens from these diseases are difficult to disperse the pathogens to other infants. Other diseases showed a relatively even age-distribution throughout childhood, though peak ages were slightly different across the diseases. This suggests that younger children may have less chance on exposure to the pathogens and older children and young adult groups may have immunity or tolerability to the pathogens causing the diseases.</p><p>In the annual-case pattern, cyclic epidemics were noted in MP pneumonia and aseptic meningitis, and marked fluctuated cases with a different peak week were noted in influenza. The annual-case pattern in KD was relatively even, but fluctuations in annual cases were noted as well as in APSGN, HSP and childhood asthma, and APN and ES in infectious diseases. APN may be the most common systemic bacterial infection in early childhood in developed countries (<xref rid="B23" ref-type="bibr">23</xref>). A majority of uropathogens causing APN in infants are <italic>E. coli</italic> or other uropathogens such as <italic>Klebsiella</italic> spp., <italic>Proteus</italic> spp., and <italic>Enterococcus</italic> spp., and they may originate from the intestinal commensals in the host. It is possible that after colonization of a strain of <italic>E. coli</italic> or other uropathoegns transferred from other persons, the pathogens invade into the host on occasional events and elicit immune reactions (<xref rid="B24" ref-type="bibr">24</xref>). Although KD and APN affect mainly infants and young children, older children and adults are also affected (<xref rid="B25" ref-type="bibr">25</xref>). Moreover, recurrent cases are not uncommon in the both diseases. These findings suggest that immature immune function in early childhood may be associated with both diseases, and pathogens may be multiple in KD (<xref rid="B11" ref-type="bibr">11</xref>). ES is an acute systemic viral infection, and is characterized by sudden appearances of generalized maculopapular or morbilliform rashes just after defervescence. The etiologic agent is a species belonging to the human Herpes virus group, herpes virus type 6 or rarely type 7. Herpes viruses have a characteristic of latent infections after initial infection. ES may have no differences in age predilection, possibly sero-prevalence rate, and clinical manifestations across populations around the world and have occurred throughout every year with no seasonal variations (<xref rid="B26" ref-type="bibr">26</xref>, <xref rid="B27" ref-type="bibr">27</xref>). Herpes virus groups become latent in the host after the initial infection as shown in herpes zoster, herpes labialis, and reactivation of cytomegalovirus and Epstein-Barr virus (EBV) in depressed immune state of the host (<xref rid="B28" ref-type="bibr">28</xref>). It was reported that EBV infection or herpes virus 6 infection was related to certain clinical manifestations in KD such as otorrhea or BCG inoculation site inflammation (<xref rid="B29" ref-type="bibr">29</xref>, <xref rid="B30" ref-type="bibr">30</xref>). It is a reasonable presumption that etiologic viruses in ES may have been introduced to humans a long-time ago, and may be coexisting within healthy human reservoirs including family members of infected infants with ES, and can be activated at any time. On occasion, the latent viruses in healthy carriers who may have a transient immune disturbance, can be reactivated and be spread to infants who have no immunity to the viruses.</p><p>In the present study, monthly case or seasonal case patterns in KD were also the most similar to those in APN or ES. Similar to this study, Nagao et al. (<xref rid="B31" ref-type="bibr">31</xref>) reported that the super-annual periodicity of KD was the most similar to ES among seven childhood infectious diseases including ES, herpangina, hand-foot-mouth disease, chicken pox, pharyngoconjunctival fever, erythema infectiosum, and GAS infection. They suggested that the KD pathogen is transmitted through close contact and persists asymptomatically in most hosts, likely ES (<xref rid="B31" ref-type="bibr">31</xref>), and this suggestion is accordance with our presumed characteristics of KD pathogens. Although the rate of KD has slowly increased with slight seasonal predominance in nationwide studies in Japan and Korea (<xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B32" ref-type="bibr">32</xref>), KD has occurred with annual fluctuations with seasonal variation each year in a given location as shown in this study. These data suggest that KD appears as local outbreaks rather than as a simultaneous nationwide epidemic as shown in viral or MP infections in Korea.</p><p>We have proposed that KD pathogens may be a species of normal flora of the host (<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B11" ref-type="bibr">11</xref>). The disturbance of microbiota of the host, i.e., dysbiosis, has been reported in a variety of diseases, including obesity, autism spectrum disorders, allergic diseases, cancers, and autoimmune diseases such as inflammatory bowel disease, JIA and KD (<xref rid="B33" ref-type="bibr">33</xref>&#x02013;<xref rid="B38" ref-type="bibr">38</xref>). It has been known that microbiota differ across ethnic groups along with different cultural environments such as diets, antibiotic use, and possibly genetic factors (<xref rid="B39" ref-type="bibr">39</xref>&#x02013;<xref rid="B41" ref-type="bibr">41</xref>). Kinumaki et al. reported that <italic>Streptococcus</italic> spp. in intestinal microbiota markedly increased during the acute phase of KD, and suggested that KD-related streptococci may be involved in the pathogenesis of KD (<xref rid="B38" ref-type="bibr">38</xref>). Recently, Esposito et al. reviewed the possible role of the microbiota-host partnership on etiology and pathogenesis of KD (<xref rid="B42" ref-type="bibr">42</xref>). Because normal flora spread via colonization in individuals in populations, a new disease that is associated with normal flora may take a long period of time during which to spread, and would show different incidences across populations at given times as shown in KD epidemiology in Asian countries. Since pathogens exist in healthy human reservoirs as normal flora, the diseases may occur mainly in immunologically or genetically susceptible groups such as young children group that have developing immune system and microbiota (<xref rid="B43" ref-type="bibr">43</xref>, <xref rid="B44" ref-type="bibr">44</xref>). Also, the epidemiology in these diseases can change over time along with an increasing number of people who obtain pathogens as normal flora in the populations, since normal flora that have adapted to the host may be less virulent compared to initial external pathogens. For example, scarlet fever caused by Group A beta-hemolytic streptococcus (GAS) was a severe disease in the past, with two notorious complications: acute rheumatic fever (ARF) and APSGN. Now, scarlet fever, ARF and APSGN have become rare diseases with a milder clinical phenotype in the developed countries (<xref rid="B17" ref-type="bibr">17</xref>, <xref rid="B45" ref-type="bibr">45</xref>). However, pharyngitis caused by GAS without complications is not uncommon, and a relatively high proportion of GAS carriers among healthy children have been reported in the developed countries (<xref rid="B46" ref-type="bibr">46</xref>, <xref rid="B47" ref-type="bibr">47</xref>). In addition, GAS strains have been susceptible to penicillin throughout the antibiotic era, with few genetic variations (<xref rid="B48" ref-type="bibr">48</xref>). Given that the evolutional purpose of external pathogens may be to become a species of normal flora in the host, these findings suggest that GAS strains may be changing to be part of normal flora in humans, though ARF still occurs in small populations (<xref rid="B49" ref-type="bibr">49</xref>). Thus, it is natural that initially severe diseases take on milder phenotypes over time, as shown in scarlet fever, pandemic influenza, and AIDS (<xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B45" ref-type="bibr">45</xref>, <xref rid="B50" ref-type="bibr">50</xref>). It was also reported that recently diagnosed KD patients showed a less severe clinical phenotype, manifesting a higher incidence of incomplete KD and a lower incidence of CALs and less activated laboratory values such as C-reactive protein and albumin compared to patients who developed the disease in earlier periods (<xref rid="B51" ref-type="bibr">51</xref>).</p><p>Pathogenesis of KD and APN as well as other infectious and immune-mediated diseases remains to be further studied. APN has a focus in renal cortical parenchyma, where replicated uropathogens, byproducts from APN agents such as toxins and pathogen-associated molecular patterns (PAMPs), substances from injured host cells, and those from activated immune cells are produced. When these diverse substances spread from the focus into systemic circulation, clinical manifestations such as fever, tissue cell injury and/or bacteremia begin to occur, and the host immune system may respond to the substances. The majority of patients infected with APN pathogens may be asymptomatic and their disease are self-limited if systemic spread did not occur and the substances in the focus were controlled as a localized inflammation (<xref rid="B24" ref-type="bibr">24</xref>). On the other hand, ARF or APSGN are classic representatives of infection-related immune-mediated disease. In ARF, after 1&#x02013;4 weeks after initial GAS infection when symptoms and signs of the initial bacterial infection (pharyngitis) subside, acute onset of fever and other symptoms, such as carditis, arthritis, and rarely skin rash (erythema marginatum), develop (<xref rid="B49" ref-type="bibr">49</xref>). The majority of patients with ARF or APSGN show a self-limited clinical course, although severely affected patients have long-term complications such as severe rheumatic heart disease or chronic renal failure, similar to giant coronary artery aneurysms in KD. Only a small proportion of patients with GAS infection are affected with ARF or APSGN. Some patients with ARF or APSGN may have preceding asymptomatic GAS infections, and other group streptococci, other bacteria or viruses are associated with postinfectious glomerulonephritis or heart tissue inflammation, including myocarditis and possibly heart valve diseases, without evidence of GAS infection (<xref rid="B52" ref-type="bibr">52</xref>, <xref rid="B53" ref-type="bibr">53</xref>). It is believed that there are etiologic substances that induce various clinical manifestations in KD as well as in ARF and APSGN after initial infection (<xref rid="B10" ref-type="bibr">10</xref>). These substances include not only those originating from the pathogens but also those from the injured host cells, including damage-associated molecular patterns (DAMPs) and those from immune cells activated by infectious insults. It have been proposed that these substances bind to specific target cells of organs such as heart and joints in ARF, kidneys in APSGN, or coronary arteries or other organs in KD. The host immune system may control these substances based on their size and biochemical properties (the protein-homeostasis-system hypothesis) (<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B54" ref-type="bibr">54</xref>, <xref rid="B55" ref-type="bibr">55</xref>).</p><p>Based on the data from epidemiological and clinical studies of KD, the pathogenesis of KD could be explained as follows. Along with economic growth and westernization in East Asian countries in order of Japan, South Korea, Taiwan, and China, a species in normal flora (microbiota) in people may be affected by environmental changes such as improved hygiene or increased consumption of westernized foods including red meats (<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B11" ref-type="bibr">11</xref>). These species (KD agents) slowly spread via colonization as normal flora to other people, including the parents and guardians of KD patients, and are eventually colonized in infants and young children predisposed to KD. On occasion, colonized KD agents invade the host via unknown events; if they are intestinal commensals, a mechanism similar to APN (via hematogeneous route in young infants) may be activated (<xref rid="B24" ref-type="bibr">24</xref>). Invading KD pathogens make a focus (replication site) elsewhere within the host, possibly near the upper respiratory or intestinal tracts (portal of entry) or in the target organ via systemic or local circulation. The majority of patients infected by the KD agents may be asymptomatic and have self-limited disease. However, during or after recovery from this infection, similar to ARF or APSGN, KD develops when the substances from a focus spread abruptly into systemic circulation (<xref rid="B10" ref-type="bibr">10</xref>). There are various incubation periods in ARF and APSGN after initial GAS infection, and no intact pathogens or structural components of the pathogen have been detected in the pathologic lesions in ARF, APSGN, KD, and other infection-related immune-mediated diseases. Furthermore, GAS strains can reside in intracellular compartments in host cells such as tonsillar epithelial cells and macrophages (<xref rid="B56" ref-type="bibr">56</xref>, <xref rid="B57" ref-type="bibr">57</xref>), and small extracellular bacteria such as mycoplasma species can proliferate within cells and spread to other organ cells (<xref rid="B58" ref-type="bibr">58</xref>). Therefore, it is possible that the etiologic substances may originate from injured host cells, including a kind of DAMPs, or from immune cells exposed to infectious insults, than from various pathogens. Immune/repair system of the host, including immunoglobulins (IgG, IgM, and IgM) and platelets, begin to control the substances and take part in tissue cell repair (<xref rid="B59" ref-type="bibr">59</xref>). Thus, the prognoses of KD and other immune-mediated diseases depend on the ability of the host immune system to control the diverse substances from target cells injured by initial insults. Early immune modulators (corticosteroids or intravenous immunoglobulin) may act on hyperactive immune reactions performed by the non-specific adaptive immune cells (T cells and B cells) in the early stage of each disease (<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B54" ref-type="bibr">54</xref>, <xref rid="B60" ref-type="bibr">60</xref>). However, despite early treatment, a few patients with KD experience severe or giant aneurysms, and these patients may have insufficient immune function to control the substances originating from injured target cells (<xref rid="B61" ref-type="bibr">61</xref>). Young children with immature immune function may be prone to invasion of KD pathogens as occurs in APN in infants, and the probability of invasion of KD agents in young children may be similar across different populations (<xref rid="B20" ref-type="bibr">20</xref>). Since microbiota may differ across populations, marked differences in racial incidence in KD or other immune-mediated diseases such as HSP, inflammatory bowel disease, and Bechet disease may be associated with the colonization state of the different etiologic agents in the populations (<xref rid="B20" ref-type="bibr">20</xref>).</p><p>This retrospective study has some limitations. Epidemiological data observed in a single hospital may not match the nationwide data. However, we found that outbreaks of infectious diseases such as MP pneumonia, influenza, and aseptic meningitis in our city had occurred concurrently with nationwide epidemics. Demographic and some epidemiologic characteristics of KD, APN, APSGN, HSP, childhood asthma, and possibly ES were similar to the data in published papers in Korea (data not shown).</p><p>In conclusion, epidemiological characteristics of KD were similar to APN or ES in age distribution, annual case pattern, and seasonal variations. The pathogens of APN and ES could be regarded as one species of normal flora, since they may have originated from the host itself or ubiquitously existing human reservoirs. KD may also be associated with a species in the normal flora that may be influenced by environmental changes.</p></sec><sec id="s5"><title>Ethics Statement</title><p>The written informed consents were obtained from the parents/caregivers of all children for the medical records to be used in this study at time of admission. The study was approved by the Institutional Review Board of The Catholic University of Korea Daejeon St. Mary's Hospital (DC18RESI0100).</p></sec><sec id="s6"><title>Author Contributions</title><p>K-YL designed the study, collected data, contributed to interpretation of results, and drafted the manuscript. J-WR contributed to data collection and drafted the initial manuscript. HK and J-WH contributed to data collection and revised the manuscript. All authors have read and approved submission of the final version of the manuscript.</p><sec><title>Conflict of Interest Statement</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></sec></body><back><ack><p>The authors would like to acknowledge our colleges on data collection during the study periods of each disease.</p></ack><ref-list><title>References</title><ref id="B1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawasaki</surname><given-names>T</given-names></name></person-group>
<article-title>Acute febrile muco-cutaneous lymph node syndrome in young children with unique digital desquamation</article-title>. <source>Arerugi.</source> (<year>1967</year>)<volume>16</volume>:<fpage>178</fpage>&#x02013;<lpage>222</lpage>.<pub-id pub-id-type="pmid">6062087</pub-id></mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>JS</given-names></name><name><surname>Suh</surname><given-names>CJ</given-names></name><name><surname>Cho</surname><given-names>SH</given-names></name><name><surname>Lee</surname><given-names>DB</given-names></name></person-group>
<article-title>Mucocutaneous lymph node syndrome: five case report</article-title>. <source>J Korean Pediatr Soc.</source> (<year>1973</year>) <volume>16</volume>:<fpage>61</fpage>&#x02013;<lpage>7</lpage>.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lue</surname><given-names>HC</given-names></name><name><surname>Philip</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>MR</given-names></name><name><surname>Wang</surname><given-names>JK</given-names></name><name><surname>Wu</surname><given-names>MH</given-names></name></person-group>. <article-title>Surveillance of Kawasaki disease in Taiwan and review of the literature</article-title>. <source>Acta Paediatr Taiwan</source>. (<year>2004</year>) <volume>45</volume>:<fpage>8</fpage>&#x02013;<lpage>14</lpage>.<?supplied-pmid 15264699?><pub-id pub-id-type="pmid">15264699</pub-id></mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>T</given-names></name><name><surname>Yanagawa</surname><given-names>H</given-names></name><name><surname>Nakamura</surname><given-names>Y</given-names></name></person-group>. <article-title>The profiles of Kawasaki disease in China</article-title>. <source>J Epidemiol</source>. (<year>2001</year>) <volume>11</volume>:<fpage>103</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.2188/jea.11.103</pub-id><?supplied-pmid 11434420?><pub-id pub-id-type="pmid">11434420</pub-id></mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uehara</surname><given-names>R</given-names></name><name><surname>Belay</surname><given-names>ED</given-names></name></person-group>. <article-title>Epidemiology of Kawasaki disease in Asia, Europe, and the United States</article-title>. <source>J Epidemiol.</source> (<year>2012</year>) <volume>22</volume>:<fpage>79</fpage>&#x02013;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.2188/jea.JE20110131</pub-id><?supplied-pmid 22307434?><pub-id pub-id-type="pmid">22307434</pub-id></mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>S</given-names></name><name><surname>Vignesh</surname><given-names>P</given-names></name><name><surname>Burgner</surname><given-names>D</given-names></name></person-group>. <article-title>The epidemiology of Kawasaki disease: a global update</article-title>. <source>Arch Dis Child.</source> (<year>2015</year>) <volume>100</volume>:<fpage>1084</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1136/archdischild-2014-307536</pub-id><?supplied-pmid 26111818?><pub-id pub-id-type="pmid">26111818</pub-id></mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCrindle</surname><given-names>BW</given-names></name><name><surname>Rowley</surname><given-names>AH</given-names></name><name><surname>Newburger</surname><given-names>JW</given-names></name><name><surname>Burns</surname><given-names>JC</given-names></name><name><surname>Bolger</surname><given-names>AF</given-names></name><name><surname>Gewitz</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Diagnosis, treatment, and long-term management of kawasaki disease: a scientific statement for health professionals from the American Heart Association</article-title>. <source>Circulation.</source> (<year>2017</year>) <volume>135</volume>:<fpage>e927</fpage>&#x02013;<lpage>99</lpage>. <pub-id pub-id-type="doi">10.1161/CIR.0000000000000484</pub-id><?supplied-pmid 28356445?><pub-id pub-id-type="pmid">28356445</pub-id></mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>K&#x000fc;hne</surname><given-names>T</given-names></name></person-group>. <article-title>Diagnosis and management of immune thrombocytopenia in childhood</article-title>. <source>Hamostaseologie.</source> (<year>2017</year>) <volume>37</volume>:<fpage>36</fpage>&#x02013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.5482/HAMO-16-06-0017</pub-id><?supplied-pmid 27699328?><pub-id pub-id-type="pmid">27699328</pub-id></mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>JY</given-names></name><name><surname>Mao</surname><given-names>JH</given-names></name></person-group>. <article-title>Henoch-Sch&#x000f6;nlein purpura nephritis in children: incidence, pathogenesis and management</article-title>. <source>World J Pediatr</source>. (<year>2015</year>) <volume>11</volume>:<fpage>29</fpage>&#x02013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1007/s12519-014-0534-5</pub-id><?supplied-pmid 25557596?><pub-id pub-id-type="pmid">25557596</pub-id></mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>KY</given-names></name><name><surname>Rhim</surname><given-names>JW</given-names></name><name><surname>Kang</surname><given-names>JH</given-names></name></person-group>. <article-title>Kawasaki disease: laboratory findings and an immunopathogenesis on the premise of a &#x0201c;protein homeostasis system&#x0201d;</article-title>. <source>Yonsei Med J.</source> (<year>2012</year>) <volume>53</volume>:<fpage>262</fpage>&#x02013;<lpage>75</lpage>. <pub-id pub-id-type="doi">10.3349/ymj.2012.53.2.262</pub-id><?supplied-pmid 22318812?><pub-id pub-id-type="pmid">22318812</pub-id></mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>KY</given-names></name><name><surname>Han</surname><given-names>JW</given-names></name><name><surname>Lee</surname><given-names>JS</given-names></name></person-group>. <article-title>Kawasaki disease may be a hyperimmune reaction of genetically susceptible children to variants of normal environmental flora</article-title>. <source>Med Hypotheses.</source> (<year>2007</year>) <volume>69</volume>:<fpage>642</fpage>&#x02013;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1016/j.mehy.2006.12.051</pub-id><?supplied-pmid 17337130?><pub-id pub-id-type="pmid">17337130</pub-id></mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>EK</given-names></name><name><surname>Youn</surname><given-names>YS</given-names></name><name><surname>Rhim</surname><given-names>JW</given-names></name><name><surname>Shin</surname><given-names>MS</given-names></name><name><surname>Kang</surname><given-names>JH</given-names></name><name><surname>Lee</surname><given-names>KY</given-names></name></person-group>. <article-title>Epidemiological comparison of three <italic>Mycoplasma pneumoniae</italic> pneumonia epidemics in a single hospital over 10 years</article-title>. <source>Korean J Pediatr.</source> (<year>2015</year>) <volume>58</volume>:<fpage>172</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.3345/kjp.2015.58.5.172</pub-id><?supplied-pmid 26124847?><pub-id pub-id-type="pmid">26124847</pub-id></mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rhim</surname><given-names>JW</given-names></name><name><surname>Go</surname><given-names>EJ</given-names></name><name><surname>Lee</surname><given-names>KY</given-names></name><name><surname>Youn</surname><given-names>YS</given-names></name><name><surname>Kim</surname><given-names>MS</given-names></name><name><surname>Park</surname><given-names>SH</given-names></name><etal/></person-group>. <article-title>Pandemic 2009 H1N1 virus infection in children and adults: A cohort study at a single hospital throughout the epidemic</article-title>. <source>Int Arch Med.</source> (<year>2012</year>) <volume>5</volume>:<fpage>13</fpage>. <pub-id pub-id-type="doi">10.1186/1755-7682-5-13</pub-id><?supplied-pmid 22443897?><pub-id pub-id-type="pmid">22443897</pub-id></mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rhim</surname><given-names>JW</given-names></name><name><surname>Lee</surname><given-names>KY</given-names></name><name><surname>Youn</surname><given-names>YS</given-names></name><name><surname>Kang</surname><given-names>JH</given-names></name><name><surname>Kim</surname><given-names>JC</given-names></name></person-group>. <article-title>Epidemiological and clinical characteristics of childhood pandemic 2009 H1N1 virus infection: an observational cohort study</article-title>. <source>BMC Infect Dis.</source> (<year>2011</year>) <volume>11</volume>:<fpage>225</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2334-11-225</pub-id><?supplied-pmid 21864391?><pub-id pub-id-type="pmid">21864391</pub-id></mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>KY</given-names></name><name><surname>Burgner</surname><given-names>D</given-names></name><name><surname>Lee</surname><given-names>HS</given-names></name><name><surname>Hong</surname><given-names>JH</given-names></name><name><surname>Lee</surname><given-names>MH</given-names></name><name><surname>Kang</surname><given-names>JH</given-names></name><etal/></person-group>. <article-title>The changing epidemiology of pediatric aseptic meningitis in Daejeon, Korea from 1987 to 2003</article-title>. <source>BMC Infect Dis.</source> (<year>2005</year>) <volume>5</volume>:<fpage>97</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2334-5-97</pub-id><?supplied-pmid 16262909?><pub-id pub-id-type="pmid">16262909</pub-id></mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huh</surname><given-names>SM</given-names></name><name><surname>Park</surname><given-names>BK</given-names></name><name><surname>Kang</surname><given-names>HM</given-names></name><name><surname>Rhim</surname><given-names>JW</given-names></name><name><surname>Suh</surname><given-names>JS</given-names></name><name><surname>Lee</surname><given-names>KY</given-names></name></person-group>
<article-title>Clinical implications of DMSA scan in childhood acute pyelonephritis</article-title>. <source>Child Kidney Dis.</source> (<year>2017</year>) <volume>21</volume>:<fpage>107</fpage>&#x02013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.3339/jkspn.2017.21.2.107</pub-id></mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuem</surname><given-names>SW</given-names></name><name><surname>Hur</surname><given-names>SM</given-names></name><name><surname>Youn</surname><given-names>YS</given-names></name><name><surname>Rhim</surname><given-names>JW</given-names></name><name><surname>Suh</surname><given-names>JS</given-names></name><name><surname>Lee</surname><given-names>KY</given-names></name></person-group>
<article-title>Changes in acute poststreptococcal glomerulonephritis: an observation study at a single Korean hospital over two decades</article-title>. <source>Child Kidney Dis.</source> (<year>2015</year>) <volume>19</volume>:<fpage>112</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.3339/chikd.2015.19.2.112</pub-id></mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rhim</surname><given-names>JW</given-names></name><name><surname>Kang</surname><given-names>HM</given-names></name><name><surname>Yang</surname><given-names>EA</given-names></name><name><surname>KY</surname><given-names>Lee</given-names></name></person-group>. <article-title>Epidemiological relationship between <italic>Mycoplasma pneumoniae</italic> pneumonia and recurrent wheezing episode in children: an observational study at a single hospital in Korea</article-title>. <source>BMJ Open.</source> (<year>2019</year>) <volume>9</volume>:<fpage>e026461</fpage>. <pub-id pub-id-type="doi">10.1136/bmjopen-2018-026461</pub-id><?supplied-pmid 30975681?><pub-id pub-id-type="pmid">30975681</pub-id></mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>KY</given-names></name><name><surname>Han</surname><given-names>JW</given-names></name><name><surname>Lee</surname><given-names>HS</given-names></name><name><surname>Hong</surname><given-names>JH</given-names></name><name><surname>Hahn</surname><given-names>SH</given-names></name><name><surname>Lee</surname><given-names>JS</given-names></name><etal/></person-group>. <article-title>Epidemiologic study of Kawasaki disease at a single hospital in Daejeon, Korea (1987 through 2000)</article-title>. <source>Pediatr Infect Dis J.</source> (<year>2004</year>) <volume>23</volume>:<fpage>52</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1097/01.inf.0000105201.92839.ec</pub-id><?supplied-pmid 14743047?><pub-id pub-id-type="pmid">14743047</pub-id></mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rhim</surname><given-names>JW</given-names></name><name><surname>Youn</surname><given-names>YS</given-names></name><name><surname>Han</surname><given-names>JW</given-names></name><name><surname>Lee</surname><given-names>SJ</given-names></name><name><surname>Oh</surname><given-names>JH</given-names></name><name><surname>Lee</surname><given-names>KY</given-names></name></person-group>. <article-title>Changes in Kawasaki disease during 2 decades at a single institution in Daejeon, Korea</article-title>. <source>Pediatr Infect Dis J.</source> (<year>2014</year>) <volume>33</volume>:<fpage>372</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1097/INF.0000000000000123</pub-id><?supplied-pmid 24145172?><pub-id pub-id-type="pmid">24145172</pub-id></mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>YW</given-names></name><name><surname>Park</surname><given-names>IS</given-names></name><name><surname>Kim</surname><given-names>CH</given-names></name><name><surname>Ma</surname><given-names>JS</given-names></name><name><surname>Lee</surname><given-names>SB</given-names></name><name><surname>Kim</surname><given-names>CH</given-names></name><etal/></person-group>. <article-title>Epidemiologic study of Kawasaki disease in Korea, 1997-1999: comparison with previous studies during 1991-1996</article-title>. <source>J Korean Med Sci.</source> (<year>2002</year>) <volume>17</volume>:<fpage>453</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.3346/jkms.2002.17.4.453</pub-id><?supplied-pmid 12172037?><pub-id pub-id-type="pmid">12172037</pub-id></mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>GB</given-names></name><name><surname>Park</surname><given-names>S</given-names></name><name><surname>Eun</surname><given-names>LY</given-names></name><name><surname>Han</surname><given-names>JW</given-names></name><name><surname>Lee</surname><given-names>SY</given-names></name><name><surname>Yoon</surname><given-names>KL</given-names></name><etal/></person-group>. <article-title>Epidemiology and clinical features of Kawasaki disease in South Korea, 2012-2014</article-title>. <source>Pediatr Infect Dis J.</source> (<year>2017</year>) <volume>36</volume>:<fpage>482</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1097/INF.0000000000001474</pub-id><?supplied-pmid 27997519?><pub-id pub-id-type="pmid">27997519</pub-id></mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhat</surname><given-names>RG</given-names></name><name><surname>Katy</surname><given-names>TA</given-names></name><name><surname>Place</surname><given-names>FC</given-names></name></person-group>. <article-title>Pediatric urinary tract infections</article-title>. <source>Emerg Med Clin North Am.</source> (<year>2011</year>) <volume>29</volume>:<fpage>637</fpage>&#x02013;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1016/j.emc.2011.04.004</pub-id><?supplied-pmid 21782079?><pub-id pub-id-type="pmid">21782079</pub-id></mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>KY</given-names></name></person-group>
<article-title>New insights for febrile urinary tract infection (acute pyelonephritis) in children</article-title>. <source>Child Kidney Dis.</source> (<year>2016</year>) <volume>20</volume>:<fpage>37</fpage>&#x02013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.3339/jkspn.2016.20.2.37</pub-id></mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kontopoulou</surname><given-names>T</given-names></name><name><surname>Kontopoulos</surname><given-names>DG</given-names></name><name><surname>Vaidakis</surname><given-names>E</given-names></name><name><surname>Mousoulis</surname><given-names>GP</given-names></name></person-group>. <article-title>Adult Kawasaki disease in a European patient: a case report and review of the literature</article-title>. <source>J Med Case Rep</source>. (<year>2015</year>) <volume>9</volume>:<fpage>75</fpage>. <pub-id pub-id-type="doi">10.1186/s13256-015-0516-9</pub-id><?supplied-pmid 25890055?><pub-id pub-id-type="pmid">25890055</pub-id></mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Enders</surname><given-names>G</given-names></name><name><surname>Biber</surname><given-names>M</given-names></name><name><surname>Meyer</surname><given-names>G</given-names></name><name><surname>Helftenbein</surname><given-names>E</given-names></name></person-group>. <article-title>Prevalence of antibodies to human herpesvirus 6 in different age groups, in children with exanthema subitum, other acute exanthematous childhood diseases, Kawasaki syndrome, and acute infections with other herpesviruses and HIV</article-title>. <source>Infection.</source> (<year>1990</year>) <volume>18</volume>:<fpage>12</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1007/BF01644173</pub-id><?supplied-pmid 2155875?><pub-id pub-id-type="pmid">2155875</pub-id></mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agut</surname><given-names>H</given-names></name><name><surname>Bonnafous</surname><given-names>P</given-names></name><name><surname>Gautheret-Dejean</surname><given-names>A</given-names></name></person-group>. <article-title>Update on infections with human herpesviruses 6A, 6B, and 7</article-title>. <source>Med Mal Infect.</source> (<year>2017</year>) <volume>47</volume>:<fpage>83</fpage>&#x02013;<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1016/j.medmal.2016.09.004</pub-id><?supplied-pmid 27773488?><pub-id pub-id-type="pmid">27773488</pub-id></mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collins-McMillen</surname><given-names>D</given-names></name><name><surname>Goodrum</surname><given-names>FD</given-names></name></person-group>. <article-title>The loss of binary: Pushing the herpesvirus latency paradigm</article-title>. <source>Curr Clin Microbiol Rep</source>. (<year>2017</year>) <volume>4</volume>:<fpage>124</fpage>&#x02013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1007/s40588-017-0072-8</pub-id><?supplied-pmid 29250481?><pub-id pub-id-type="pmid">29250481</pub-id></mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pavone</surname><given-names>P</given-names></name><name><surname>Cocuzza</surname><given-names>S</given-names></name><name><surname>Passaniti</surname><given-names>E</given-names></name><name><surname>Longo</surname><given-names>MR</given-names></name><name><surname>Verrotti</surname><given-names>A</given-names></name><name><surname>Serra</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Otorrhea in Kawasaki disease diagnosis complicated by an EBV infection: coincidental disease or a true association</article-title>. <source>Eur Rev Med Pharmacol Sci.</source> (<year>2013</year>) <volume>17</volume>:<fpage>989</fpage>&#x02013;<lpage>93</lpage>.<pub-id pub-id-type="pmid">23640449</pub-id></mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kakisaka</surname><given-names>Y</given-names></name><name><surname>Ohara</surname><given-names>T</given-names></name><name><surname>Katayama</surname><given-names>S</given-names></name><name><surname>Suzuki</surname><given-names>T</given-names></name><name><surname>Sasai</surname><given-names>S</given-names></name><name><surname>Hino-Fukuyo</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>Human herpes virus type 6 can cause skin lesions at the BCG inoculation site similar to Kawasaki disease</article-title>. <source>Tohoku J Exp Med</source>. (<year>2012</year>) <volume>228</volume>:<fpage>351</fpage>&#x02013;<lpage>3</lpage>. <pub-id pub-id-type="doi">10.1620/tjem.228.351</pub-id><?supplied-pmid 23138414?><pub-id pub-id-type="pmid">23138414</pub-id></mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagao</surname><given-names>Y</given-names></name><name><surname>Urabe</surname><given-names>C</given-names></name><name><surname>Nakamura</surname><given-names>H</given-names></name><name><surname>Hatano</surname><given-names>N</given-names></name></person-group>
<article-title>Predicting the characteristics of the aetiological agent for Kawasaki disease from other paediatric infectious diseases in Japan</article-title>. <source>Epidemiol Infect.</source> (<year>2016</year>) <volume>144</volume>:<fpage>478</fpage>&#x02013;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1017/S0950268815001223</pub-id><pub-id pub-id-type="pmid">26201398</pub-id></mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Makino</surname><given-names>N</given-names></name><name><surname>Nakamura</surname><given-names>Y</given-names></name><name><surname>Yashiro</surname><given-names>M</given-names></name><name><surname>Ae</surname><given-names>R</given-names></name><name><surname>Tsuboi</surname><given-names>S</given-names></name><name><surname>Aoyama</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Descriptive epidemiology of Kawasaki disease in Japan, 2011-2012: from the results of the 22nd nationwide survey</article-title>. <source>J Epidemiol.</source> (<year>2015</year>) <volume>25</volume>:<fpage>239</fpage>&#x02013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.2188/jea.JE20140089</pub-id><?supplied-pmid 25716368?><pub-id pub-id-type="pmid">25716368</pub-id></mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cani</surname><given-names>PD</given-names></name><name><surname>Delzenne</surname><given-names>NM</given-names></name></person-group>. <article-title>Interplay between obesity and associated metabolic disorders: new insights into the gut microbiota</article-title>. <source>Curr Opin Pharmacol</source>. (<year>2009</year>) <volume>9</volume>:<fpage>737</fpage>&#x02013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1016/j.coph.2009.06.016</pub-id><?supplied-pmid 19628432?><pub-id pub-id-type="pmid">19628432</pub-id></mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doenyas</surname><given-names>C</given-names></name></person-group>. <article-title>Gut microbiota, inflammation, and probiotics on neural development in autism spectrum disorder</article-title>. <source>Neuroscience.</source> (<year>2018</year>) <volume>374</volume>:<fpage>271</fpage>&#x02013;<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2018.01.060</pub-id><?supplied-pmid 29427656?><pub-id pub-id-type="pmid">29427656</pub-id></mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>H&#x000f6;rmannsperger</surname><given-names>G</given-names></name><name><surname>Clave</surname><given-names>T</given-names></name><name><surname>Haller</surname><given-names>D</given-names></name></person-group>. <article-title>Gut matters: microbe-host interactions in allergic diseases</article-title>. <source>J Allergy Clin Immunol.</source> (<year>2012</year>) <volume>129</volume>:<fpage>1452</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaci.2011.12.993</pub-id><?supplied-pmid 22322009?><pub-id pub-id-type="pmid">22322009</pub-id></mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Domingue</surname><given-names>JC</given-names></name><name><surname>Sears</surname><given-names>CL</given-names></name></person-group>. <article-title>Microbiota dysbiosis in select human cancers: evidence of association and causality</article-title>. <source>Semin Immunol.</source> (<year>2017</year>) <volume>32</volume>:<fpage>25</fpage>&#x02013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1016/j.smim.2017.08.001</pub-id><?supplied-pmid 28822617?><pub-id pub-id-type="pmid">28822617</pub-id></mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arvonen</surname><given-names>M</given-names></name><name><surname>Berntson</surname><given-names>L</given-names></name><name><surname>Pokka</surname><given-names>T</given-names></name><name><surname>Karttunen</surname><given-names>TJ</given-names></name><name><surname>V&#x000e4;h&#x000e4;salo</surname><given-names>P</given-names></name><name><surname>Stoll</surname><given-names>ML</given-names></name></person-group>. <article-title>Gut microbiota-host interactions and juvenile idiopathic arthritis</article-title>. <source>Pediatr Rheumatol Online J.</source> (<year>2016</year>) <volume>14</volume>:<fpage>44</fpage>. <pub-id pub-id-type="doi">10.1186/s12969-016-0104-6</pub-id><?supplied-pmid 27448997?><pub-id pub-id-type="pmid">27448997</pub-id></mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kinumaki</surname><given-names>A</given-names></name><name><surname>Sekizuka</surname><given-names>T</given-names></name><name><surname>Hamada</surname><given-names>H</given-names></name><name><surname>Kato</surname><given-names>K</given-names></name><name><surname>Yamashita</surname><given-names>A</given-names></name><name><surname>Kuroda</surname><given-names>M</given-names></name></person-group>. <article-title>Characterization of the gut microbiota of Kawasaki disease patients by metagenomic analysis</article-title>. <source>Front Microbiol.</source> (<year>2015</year>) <volume>6</volume>:<fpage>824</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2015.00824</pub-id><?supplied-pmid 26322033?><pub-id pub-id-type="pmid">26322033</pub-id></mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name></person-group>. <article-title>Role of intestinal microbiota and metabolites on gut homeostasis and human diseases</article-title>. <source>BMC Immunol.</source> (<year>2017</year>) <volume>18</volume>:<fpage>2</fpage>. <pub-id pub-id-type="doi">10.1186/s12865-016-0187-3</pub-id><?supplied-pmid 28061847?><pub-id pub-id-type="pmid">28061847</pub-id></mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harusato</surname><given-names>A</given-names></name><name><surname>Chassaing</surname><given-names>B</given-names></name></person-group>. <article-title>Insights on the impact of diet-mediated microbiota alterations on immunity and diseases</article-title>. <source>Am J Transplant.</source> (<year>2018</year>)<volume>18</volume>:<fpage>550</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1111/ajt.14477</pub-id><?supplied-pmid 28858426?><pub-id pub-id-type="pmid">28858426</pub-id></mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Korpela</surname><given-names>K</given-names></name><name><surname>de Vos</surname><given-names>WM</given-names></name></person-group>. <article-title>Antibiotic use in childhood alters the gut microbiota and predisposes to overweight</article-title>. <source>Microb Cell.</source> (<year>2016</year>) <volume>3</volume>:<fpage>296</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.15698/mic2016.07.514</pub-id><?supplied-pmid 28357367?><pub-id pub-id-type="pmid">28357367</pub-id></mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esposito</surname><given-names>S</given-names></name><name><surname>Polinori</surname><given-names>I</given-names></name><name><surname>Rigante</surname><given-names>D</given-names></name></person-group>. <article-title>The gut microbiota-host partnership as a potential driver of Kawasaki syndrome</article-title>. <source>Front Pediatr.</source> (<year>2019</year>) <volume>7</volume>:<fpage>124</fpage>. <pub-id pub-id-type="doi">10.3389/fped.2019.00124</pub-id><?supplied-pmid 31024869?><pub-id pub-id-type="pmid">31024869</pub-id></mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wopereis</surname><given-names>H</given-names></name><name><surname>Oozeer</surname><given-names>R</given-names></name><name><surname>Knipping</surname><given-names>K</given-names></name><name><surname>Belzer</surname><given-names>C</given-names></name><name><surname>Knol</surname><given-names>J</given-names></name></person-group>. <article-title>The first thousand days - intestinal microbiology of early life: establishing a symbiosis</article-title>. <source>Pediatr Allergy Immunol</source>. (<year>2014</year>) <volume>25</volume>:<fpage>428</fpage>&#x02013;<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1111/pai.12232</pub-id><?supplied-pmid 24899389?><pub-id pub-id-type="pmid">24899389</pub-id></mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simon</surname><given-names>AK</given-names></name><name><surname>Hollander</surname><given-names>GA</given-names></name><name><surname>McMichael</surname><given-names>A</given-names></name></person-group>. <article-title>Evolution of the immune system in humans from infancy to old age</article-title>. <source>Proc Biol Sci.</source> (<year>2015</year>) <volume>282</volume>:<fpage>20143085</fpage>. <pub-id pub-id-type="doi">10.1098/rspb.2014.3085</pub-id><?supplied-pmid 26702035?><pub-id pub-id-type="pmid">26702035</pub-id></mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quinn</surname><given-names>RW</given-names></name></person-group>. <article-title>Comprehensive review of morbidity and mortality trends for rheumatic fever, streptococcal disease, and scarlet fever: the decline of rheumatic fever</article-title>. <source>Rev Infect Dis.</source> (<year>1989</year>) <volume>11</volume>:<fpage>928</fpage>&#x02013;<lpage>53</lpage>.<?supplied-pmid 2690288?><pub-id pub-id-type="pmid">2690288</pub-id></mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaplan</surname><given-names>EL</given-names></name><name><surname>Gastanaduy</surname><given-names>AS</given-names></name><name><surname>Huwe</surname><given-names>BB</given-names></name></person-group>. <article-title>The role of the carrier in treatment failures after antibiotic for group A streptococci in the upper respiratory tract</article-title>. <source>J Lab Clin Med.</source> (<year>1981</year>) <volume>98</volume>:<fpage>326</fpage>&#x02013;<lpage>35</lpage>.<?supplied-pmid 7021717?><pub-id pub-id-type="pmid">7021717</pub-id></mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roberts</surname><given-names>AL</given-names></name><name><surname>Connolly</surname><given-names>KL</given-names></name><name><surname>Kirse</surname><given-names>DJ</given-names></name><name><surname>Evans</surname><given-names>AK</given-names></name><name><surname>Poehling</surname><given-names>KA</given-names></name><name><surname>Peters</surname><given-names>TR</given-names></name><etal/></person-group>. <article-title>Detection of group A Streptococcus in tonsils from pediatric patients reveals high rate of asymptomatic streptococcal carriage</article-title>. <source>BMC Pediatr.</source> (<year>2012</year>) <volume>12</volume>:<fpage>3</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2431-12-3</pub-id><?supplied-pmid 22230361?><pub-id pub-id-type="pmid">22230361</pub-id></mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brook</surname><given-names>I</given-names></name></person-group>. <article-title>Treatment challenges of Group A beta-hemolytic streptococcal pharyngo-tonsillitis</article-title>. <source>Int Arch Otorhinolaryngol.</source> (<year>2017</year>) <volume>21</volume>:<fpage>286</fpage>&#x02013;<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1055/s-0036-1584294</pub-id><?supplied-pmid 28680500?><pub-id pub-id-type="pmid">28680500</pub-id></mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gewitz</surname><given-names>MH</given-names></name><name><surname>Baltimore</surname><given-names>RS</given-names></name><name><surname>Tani</surname><given-names>LY</given-names></name><name><surname>Sable</surname><given-names>CA</given-names></name><name><surname>Shulman</surname><given-names>ST</given-names></name><name><surname>Carapetis</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Revision of the Jones Criteria for the diagnosis of acute rheumatic fever in the era of Doppler echocardiography: a scientific statement from the American Heart Association</article-title>. <source>Circulation.</source> (<year>2015</year>) <volume>131</volume>:<fpage>1806</fpage>&#x02013;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1161/CIR.0000000000000205</pub-id><?supplied-pmid 25908771?><pub-id pub-id-type="pmid">25908771</pub-id></mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mirani</surname><given-names>G</given-names></name><name><surname>Williams</surname><given-names>PL</given-names></name><name><surname>Chernoff</surname><given-names>M</given-names></name><name><surname>Abzug</surname><given-names>MJ</given-names></name><name><surname>Levin</surname><given-names>MJ</given-names></name><name><surname>Seage</surname><given-names>GR</given-names><suffix>III</suffix></name><etal/></person-group>
<article-title>IMPAACT P1074 Study Team</article-title>. Changing trends in complications and mortality rates among US youth and young adults with HIV Infection in the era of combination antiretroviral therapy. <source>Clin Infect Dis.</source> (<year>2015</year>) <volume>61</volume>:<fpage>1850</fpage>&#x02013;<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1093/cid/civ687</pub-id><pub-id pub-id-type="pmid">26270680</pub-id></mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kil</surname><given-names>HR</given-names></name><name><surname>Yu</surname><given-names>JW</given-names></name><name><surname>Lee</surname><given-names>SC</given-names></name><name><surname>Rhim</surname><given-names>JW</given-names></name><name><surname>Lee</surname><given-names>KY</given-names></name></person-group>. <article-title>Changes in clinical and laboratory features of Kawasaki disease noted over time in Daejeon, Korea</article-title>. <source>Pediatr Rheumatol.</source> (<year>2017</year>) <volume>15</volume>:<fpage>60</fpage>. <pub-id pub-id-type="doi">10.1186/s12969-017-0192-y</pub-id><?supplied-pmid 28784161?><pub-id pub-id-type="pmid">28784161</pub-id></mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kambham</surname><given-names>N</given-names></name></person-group>. <article-title>Postinfectious glomerulonephritis</article-title>. <source>Adv Anat Pathol.</source> (<year>2012</year>) <volume>19</volume>:<fpage>338</fpage>&#x02013;<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1097/PAP.0b013e31826663d9</pub-id><?supplied-pmid 22885383?><pub-id pub-id-type="pmid">22885383</pub-id></mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trachtenberg</surname><given-names>BH</given-names></name><name><surname>Hare</surname><given-names>JM</given-names></name></person-group>. <article-title>Inflammatory cardiomyopathic syndromes</article-title>. <source>Circ Res.</source> (<year>2017</year>) <volume>121</volume>:<fpage>803</fpage>&#x02013;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.117.310221</pub-id><?supplied-pmid 28912184?><pub-id pub-id-type="pmid">28912184</pub-id></mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>KY</given-names></name></person-group>. <article-title>A common immunopathogenesis mechanism for infectious diseases: the protein-homeostasis-system hypothesis</article-title>. <source>Infect Chemother.</source> (<year>2015</year>) <volume>47</volume>:<fpage>12</fpage>&#x02013;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.3947/ic.2015.47.1.12</pub-id><?supplied-pmid 25844259?><pub-id pub-id-type="pmid">25844259</pub-id></mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>KY</given-names></name></person-group>. <article-title>A unified pathogenesis for kidney diseases, including genetic diseases and cancers, by the protein-homeostasis-system hypothesis</article-title>. <source>Kidney Res Clin Pract</source>. (<year>2017</year>) <volume>36</volume>:<fpage>132</fpage>&#x02013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.23876/j.krcp.2017.36.2.132</pub-id><?supplied-pmid 28680821?><pub-id pub-id-type="pmid">28680821</pub-id></mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Osterlund</surname><given-names>A</given-names></name><name><surname>Engstrand</surname><given-names>L</given-names></name></person-group>. <article-title>An intracellular sanctuary for <italic>Streptococcus pyogenes</italic>. in human tonsillar epithelium: studies of asymptomatic carriers and <italic>in vitro</italic> cultured biopsies</article-title>. <source>Acta Otolaryngol.</source> (<year>1997</year>) <volume>117</volume>:<fpage>883</fpage>&#x02013;<lpage>8</lpage>.<?supplied-pmid 9442832?><pub-id pub-id-type="pmid">9442832</pub-id></mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Neill</surname><given-names>AM</given-names></name><name><surname>Thurston</surname><given-names>TL</given-names></name><name><surname>Holden</surname><given-names>DW</given-names></name></person-group>
<article-title>Cytosolic replication of <italic>Group A streptococcus</italic>. in human macrophages</article-title>. <source>MBio.</source> (<year>2016</year>) <volume>7</volume>:<fpage>e00020</fpage>&#x02013;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1128/mBio.00020-16</pub-id><pub-id pub-id-type="pmid">27073088</pub-id></mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hegde</surname><given-names>S</given-names></name><name><surname>Hegde</surname><given-names>S</given-names></name><name><surname>Spergser</surname><given-names>J</given-names></name><name><surname>Brunthaler</surname><given-names>R</given-names></name><name><surname>Rosengarten</surname><given-names>R</given-names></name><name><surname>Chopra-Dewasthaly</surname><given-names>R</given-names></name></person-group>. <article-title><italic>In vitro</italic> and <italic>in vivo</italic> cell invasion and systemic spreading of <italic>Mycoplasma agalactiae</italic> in the sheep infection model</article-title>. <source>Int J Med Microbiol</source>. (<year>2014</year>) <volume>304</volume>:<fpage>1024</fpage>&#x02013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijmm.2014.07.011</pub-id><?supplied-pmid 25129554?><pub-id pub-id-type="pmid">25129554</pub-id></mixed-citation></ref><ref id="B59"><label>59.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>JW</given-names></name><name><surname>Oh</surname><given-names>JH</given-names></name><name><surname>Rhim</surname><given-names>JW</given-names></name><name><surname>Lee</surname><given-names>KY</given-names></name></person-group>. <article-title>Correlation between elevated platelet count and immunoglobulin levels in the early convalescent stage of Kawasaki disease</article-title>. <source>Medicine (Baltimore).</source> (<year>2017</year>) <volume>96</volume>:<fpage>e7583</fpage>. <pub-id pub-id-type="doi">10.1097/MD.0000000000007583</pub-id><?supplied-pmid 28723797?><pub-id pub-id-type="pmid">28723797</pub-id></mixed-citation></ref><ref id="B60"><label>60.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>KY</given-names></name></person-group>. <article-title>Pneumonia, acute respiratory distress syndrome, and early immune-modulator therapy</article-title>. <source>Int J Mol Sci.</source> (<year>2017</year>) <volume>18</volume>:<fpage>E388</fpage>. <pub-id pub-id-type="doi">10.3390/ijms18020388</pub-id><?supplied-pmid 28208675?><pub-id pub-id-type="pmid">28208675</pub-id></mixed-citation></ref><ref id="B61"><label>61.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seo</surname><given-names>YM</given-names></name><name><surname>Kang</surname><given-names>HM</given-names></name><name><surname>Lee</surname><given-names>SC</given-names></name><name><surname>Yu</surname><given-names>JW</given-names></name><name><surname>Kil</surname><given-names>HR</given-names></name><name><surname>Rhim</surname><given-names>JE</given-names></name><etal/></person-group>. <article-title>Clinical implications in laboratory parameter values in acute Kawasaki disease for early diagnosis and proper treatment</article-title>. <source>Korean J Pediatr.</source> (<year>2018</year>) <volume>61</volume>:<fpage>160</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.3345/kjp.2018.61.5.160</pub-id><?supplied-pmid 29853941?><pub-id pub-id-type="pmid">29853941</pub-id></mixed-citation></ref></ref-list></back></article>